- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : 젬시타빈
총 3052 건
-
M.D. Anderson Cancer CenterAscentage Pharma Group Inc.아직 모집하지 않음진행성 만성 골수성 백혈병 | 필라델피아 염색체 양성 급성 골수성 백혈병미국
-
Chinese PLA General Hospital모병
-
Academisch Medisch Centrum - Universiteit van Amsterdam...종료됨
-
Eisai Inc.종료됨
-
Takeda빼는
-
Peptomyc S.L.모병
-
Peking Union Medical College Hospital아직 모집하지 않음
-
Tianjin Medical University Cancer Institute and...모병
-
Academic Thoracic Oncology Medical Investigators...University of Colorado, Denver; Celgene Corporation; Criterium, Inc.모집하지 않고 적극적으로
-
Fondazione del Piemonte per l'Oncologia완전한
-
Merck Sharp & Dohme LLC완전한
-
Fudan University모집하지 않고 적극적으로
-
Fuda Cancer Hospital, Guangzhou완전한
-
NanoCarrier Co., Ltd.완전한
-
Creighton University종료됨HMG-CoA Reductase Inhibitors-related Myalgias미국
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital완전한
-
Jinling Hospital, ChinaJiangsu Hengrui Pharmaceutical Co., Ltd.모병
-
Tongji UniversityShanghai Pulmonary Hospital, Shanghai, China알려지지 않은
-
Dokuz Eylul University아직 모집하지 않음
-
Judith Dixon-HughesNHS Greater Glasgow and Clyde; University of Glasgow모병
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)모병
-
Shouyao Holdings (Beijing) Co. LTD모병
-
University of Maryland, Baltimore모병
-
Memorial Sloan Kettering Cancer CenterArray BioPharma완전한
-
Second Affiliated Hospital, School of Medicine,...알려지지 않은
-
Oncolytics Biotech빼는Muscle-invasive Transitional Cell Carcinoma of the Bladder
-
Threshold PharmaceuticalsPPD완전한
-
Massachusetts General HospitalAstex Pharmaceuticals, Inc.모병
-
Innovent Biologics (Suzhou) Co. Ltd.정지된
-
Mayo ClinicNational Cancer Institute (NCI)종료됨속발성 급성 골수성 백혈병 | 치료받지 않은 성인 급성 골수성 백혈병 | FLT3/ITD 돌연변이를 동반한 급성 골수성 백혈병 | 유전자 돌연변이를 동반한 급성 골수성 백혈병 | FLT3 티로신 키나제 도메인 포인트 돌연변이미국
-
Nevada Cancer InstituteNational Institutes of Health (NIH); Schering-Plough종료됨
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital 그리고 다른 협력자들모병Phase II, Open-label, Parallel 2-arm, Multi-center대만
-
Sorrento Therapeutics, Inc.빼는간으로 전이된 췌장의 악성종양